CBIO Crescent Biopharma, Inc. - Common Stock
$17,40
Prezzo · Ago 19, 2026
Fondamentali al Lug 30, 2026
Intervallo 52 sett.
$9–$27
46% of range
Rating Analisti
BUY
15 analysts
Prezzo Obiettivo
$31
+76% upside
P/E (TTM)
-35.5
ROE
-90.0%
Margine di Profitto Netto
-1419.6%
CBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$17.39
Capitalizzazione di Mercato
$480M
P/E (TTM)
-35.5
EPS (TTM)
$-0.59
Ricavi (TTM)
$11M
Rendimento div.
—
ROE
-90.0%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$9 – $27
CBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$11M
2016-12-31
→
2025-12-31
EPS
$-0.59
2019-12-31
→
2024-12-31
Flusso di cassa libero
$-72M
2016-12-31
→
2025-12-31
Margini
-1419.6%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
CBIO
Mediana dei peer
P/E (TTM)
-35.5
19.6
P/S (TTM)
44.2
6.4
P/B
2.4
2.6
Price / FCF (Prezzo / FCF)
-6.6
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
CBIO
Mediana dei peer
Operating Margin (Margine Operativo)
-1407.5%
—
Net Profit Margin (Margine di Profitto Netto)
-1419.6%
-104.2%
ROA
-111.6%
-40.3%
ROE
-90.0%
-42.4%
ROIC
-76.2%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
CBIO
Mediana dei peer
Current Ratio (Rapporto corrente)
6.6
5.4
Quick Ratio
6.4
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
CBIO
Mediana dei peer
Revenue YoY (Ricavi YoY)
-86.7%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
424.9%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
1.3%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
CBIO
Mediana dei peer
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
—
Rapporto di Distribuzione Utili
—
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 13 Gennaio 2023 | $24,0000 |
| 21 Settembre 2022 | $143,0000 |
CBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
15 analisti
- Acquisto forte 6 40,0%
- Compra 7 46,7%
- Mantieni 2 13,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
5 analisti · 2026-08-19
Mediana
$28.00
Media
$30.60
← Sotto tutti i target
$17.39
Basso
$27.00
Alto
$35.00
Target mediano
$28.00
+61,0%
Target medio
$30.60
+75,9%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.18%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.74 | $-0.81 | 0.07% |
| 31 Marzo 2026 | $-0.70 | $-0.97 | 0.27% |
| 31 Dicembre 2025 | $-0.54 | $-2.57 | 2.0% |
| 30 Settembre 2025 | $-1.27 | $-2.02 | 0.75% |
| 30 Giugno 2025 | $-4.93 | $-1.80 | -3.1% |
| 31 Marzo 2025 | $-4.00 | $-5.10 | 1.1% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| EIKN | — | — | — | — | — | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Stato Patrimoniale 21
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Flusso di cassa 11
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Conto Economico 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | -128,947,790 | 64,483,958 | 64,483,848 | 64,457,233 | -125,633,555 | 64,349,709 | 64,276,184 | 60,350,127 | -104,631,509 | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | -129,012,814 | 64,483,958 | 64,483,848 | 64,522,257 | -129,740,661 | 64,349,709 | 64,276,184 | 64,457,233 | -104,631,509 | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | $-2M | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Stato Patrimoniale 21
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Flusso di cassa 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Redditività 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | -11.7% | · | -28.5% | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | -14.5% | · | -33.9% | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | 2.3 | · | 3.6 | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | 2.1 | · | 3.3 | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-71M | $-57M | $-46M | · | $-40M | $-38M | $-39M | · | $-36M | $-40M | $-47M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | $1.36B | · | $1.10B | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -36.7 | -37.5 | · | -24.3 | -32.9 | -42.9 | · | -34.7 | -59.6 | -625.0 | · | -250.0 | -245.1 | -146.5 | · | -53.4 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | -265.4 | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -1838.6 | · | · | · | -697.3 | · | · | |
| Earnings Yield | -2.7% | -2.7% | · | -4.1% | -3.0% | -2.3% | · | -2.9% | -1.7% | -0.16% | · | -0.40% | -0.41% | -0.68% | · | -1.9% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $11M | — | $10.0K | $75.0K | $1M |
| Margine Operativo % | -1407.5% | — | -392752.9% | -63204.4% | -5470.7% |
| Utile netto | $-154M | $-38M | $-37M | $-47M | $-63M |
| EPS Diluito | — | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-72M | $-31M | $-35M | $-47M | $-58M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 82 filer · $470.5M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 35 (+21 vs trimestre precedente) | 12 (+2 vs trimestre precedente) | 14 (-3 vs trimestre precedente) | 15 (+7 vs trimestre precedente) | +3.5M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $51.011.496 | 2.833.972 | 10,84% | Azioni |
| BVF INC/IL | $49.477.734 | 2.748.763 | 10,52% | Azioni |
| Fairmount Funds Management LLC | $49.461.588 | 2.747.866 | 10,51% | Azioni |
| Venrock Adviser, LLC | $38.404.368 | 2.133.576 | 8,16% | Azioni |
| Logos Global Management LP | $34.200.000 | 1.900.000 | 7,27% | Azioni |
| FCPM III SERVICES B.V. | $30.201.336 | 1.677.852 | 6,42% | Azioni |
| Balyasny Asset Management L.P. | $29.932.506 | 1.662.917 | 6,36% | Azioni |
| Vestal Point Capital, LP | $29.340.000 | 1.630.000 | 6,24% | Azioni |
| Opaleye Management Inc. | $23.748.318 | 1.319.351 | 5,05% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $20.880.000 | 1.160.000 | 4,44% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.819.590 | 767.755 | 2,94% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.269.462 | 403.859 | 1,55% | Azioni |
| JENNISON ASSOCIATES LLC | $6.813.126 | 378.507 | 1,45% | Azioni |
| RTW INVESTMENTS, LP | $6.711.408 | 372.856 | 1,43% | Azioni |
| NEXTBio Capital Management LP | $6.711.408 | 372.856 | 1,43% | Azioni |
| Remedium Capital Partners, LLC | $6.502.500 | 361.250 | 1,38% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $6.056.873 | 336.411 | 1,29% | Azioni |
| VANGUARD GROUP INC | $5.984.722 | 504.614 | 1,27% | Azioni |
| STATE STREET CORP | $5.680.566 | 315.587 | 1,21% | Azioni |
| AMERIPRISE FINANCIAL INC | $5.446.224 | 302.568 | 1,16% | Azioni |
| Point72 Asset Management, L.P. | $5.400.000 | 300.000 | 1,15% | Azioni |
| PERCEPTIVE ADVISORS LLC | $3.724.956 | 206.942 | 0,79% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.398.454 | 188.803 | 0,72% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $3.363.732 | 186.874 | 0,71% | Azioni |
| STEMPOINT CAPITAL LP | $3.282.876 | 182.382 | 0,70% | Azioni |
| UBS Group AG | $3.061.674 | 170.093 | 0,65% | Azioni |
| Exome Asset Management LLC | $2.299.842 | 127.769 | 0,49% | Azioni |
| SECTORAL ASSET MANAGEMENT INC | $2.183.400 | 121.300 | 0,46% | Azioni |
| Woodline Partners LP | $1.700.784 | 94.488 | 0,36% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.354.050 | 75.225 | 0,29% | Azioni |
| Burkehill Global Management, LP | $1.332.000 | 74.000 | 0,28% | Azioni |
| Blackstone Inc. | $1.127.646 | 62.647 | 0,24% | Azioni |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.063.872 | 59.104 | 0,23% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $914.832 | 50.824 | 0,19% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904.644 | 50.258 | 0,19% | Azioni |
| Nuveen, LLC | $857.322 | 47.629 | 0,18% | Azioni |
| Stonepine Capital Management, LLC | $720.000 | 40.000 | 0,15% | Azioni |
| RHUMBLINE ADVISERS | $458.766 | 25.487 | 0,10% | Azioni |
| MOORE CAPITAL MANAGEMENT, LP | $450.000 | 25.000 | 0,10% | Azioni |
| Squarepoint Ops LLC | $434.988 | 24.166 | 0,09% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $410.490 | 22.805 | 0,09% | Azioni |
| TWO SIGMA ADVISERS, LP | $385.450 | 32.500 | 0,08% | Azioni |
| WELLS FARGO & COMPANY/MN | $354.600 | 19.700 | 0,08% | Azioni |
| ADAR1 Capital Management, LLC | $328.950 | 18.275 | 0,07% | Azioni |
| Virtus Investment Advisers, LLC | $328.644 | 18.258 | 0,07% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $319.590 | 17.755 | 0,07% | Azioni |
| BANK OF MONTREAL /CAN/ | $247.806 | 13.767 | 0,05% | Azioni |
| MetLife Investment Management, LLC | $230.040 | 12.780 | 0,05% | Azioni |
| Bank of New York Mellon Corp | $224.892 | 12.494 | 0,05% | Azioni |
| BANK OF AMERICA CORP /DE/ | $223.452 | 12.414 | 0,05% | Azioni |
| Persistent Asset Partners Ltd | $197.424 | 10.968 | 0,04% | Azioni |
| XTX Topco Ltd | $190.152 | 10.564 | 0,04% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $178.218 | 9.901 | 0,04% | Azioni |
| CITIGROUP INC | $160.110 | 8.895 | 0,03% | Azioni |
| Invesco Ltd. | $154.980 | 8.610 | 0,03% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $136.800 | 7.600 | 0,03% | Azioni |
| BlackRock, Inc. | $119.484 | 6.638 | 0,03% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $114.642 | 6.369 | 0,02% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $84.600 | 4.700 | 0,02% | Azioni |
| NORTHERN TRUST CORP | $61.128 | 3.396 | 0,01% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $59.454 | 3.303 | 0,01% | Azioni |
| MARSHALL WACE, LLP | $59.130 | 3.285 | 0,01% | Azioni |
| BARCLAYS PLC | $54.648 | 3.036 | 0,01% | Azioni |
| Vanguard Global Advisers, LLC | $48.852 | 2.714 | 0,01% | Azioni |
| Legal & General Group Plc | $37.746 | 2.097 | 0,01% | Azioni |
| Tower Research Capital LLC (TRC) | $31.500 | 1.750 | 0,01% | Azioni |
| Russell Investments Group, Ltd. | $31.068 | 1.726 | 0,01% | Azioni |
| ROYAL BANK OF CANADA | $12.000 | 661 | 0,00% | Azioni |
| US BANCORP \DE\ | $7.254 | 403 | 0,00% | Azioni |
| Parallel Advisors, LLC | $4.752 | 264 | 0,00% | Azioni |
| PRICE T ROWE ASSOCIATES INC /MD/ | $4.488 | 249.312 | 0,00% | Azioni |
| Allworth Financial LP | $2.898 | 161 | 0,00% | Azioni |
| Sterling Capital Management LLC | $1.368 | 76 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $1.224 | 68 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $1.206 | 67 | 0,00% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $900 | 50 | 0,00% | Azioni |
| MORGAN STANLEY | $792 | 44 | 0,00% | Azioni |
| Fortitude Family Office, LLC | $720 | 40 | 0,00% | Azioni |
| Quarry LP | $522 | 29 | 0,00% | Azioni |
| OSAIC HOLDINGS, INC. | $468 | 26 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $378 | 21 | 0,00% | Azioni |
| NATIONAL BANK OF CANADA /FI/ | $54 | 3 | 0,00% | Azioni |
Insider aziendali 33 insider · 15 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | 22 Giugno 2026 S | 281.212 | 0 | 1 | $-761.067 |
| Harout Semerjian | Chief Executive Officer | 12 Gennaio 2024 A | 25.000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | 22 Giugno 2026 S | 20.298 | 0 | 1 | $-20.005 |
| Brian M. Hahn | SVP Finance, CFO | 12 Gennaio 2024 A | 53.143 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | 22 Giugno 2026 S | 139.158 | 0 | 1 | $-369.677 |
| Jan Pinkas | Chief Scientific Officer | 22 Giugno 2026 S | 22.239 | 0 | 1 | $-23.171 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 22 Giugno 2026 S | 19.330 | 0 | 1 | $-21.912 |
| Ellie Eunkyung Im | Chief Medical Officer | 22 Giugno 2026 S | 22.069 | 0 | 1 | $-21.930 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 22 Giugno 2026 S | 13.871 | 0 | 1 | $-8.365 |
| Bruce S Johnson | SVP & Chief Commercial Officer | 12 Gennaio 2024 A | 138.980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | 12 Gennaio 2024 A | — | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | 12 Gennaio 2024 A | 375.403 | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | 11 Novembre 2022 P | 29.161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | 11 Novembre 2022 P | 366.078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | 20 Gennaio 2021 A | 183.115 | 0 | 0 | $0 |
| Alexandra Balcom | Direttore | 02 Giugno 2026 A | — | 0 | 0 | $0 |
| Susan Moran | Direttore | 02 Giugno 2026 A | — | 0 | 0 | $0 |
| Jonathan Violin | Direttore | 02 Giugno 2026 A | — | 0 | 0 | $0 |
| David Charles Lubner | Direttore | 02 Giugno 2026 A | — | 0 | 0 | $0 |
| Rachel K. King | Direttore | 29 Dicembre 2023 A | 511.860 | 0 | 0 | $0 |
| Mark Alan Goldberg | Direttore | 29 Dicembre 2023 A | 20.244 | 0 | 0 | $0 |
| Patricia S Andrews | Direttore | 29 Dicembre 2023 A | 58.608 | 0 | 0 | $0 |
| Scott Koenig | Direttore | 01 Giugno 2023 M | 36.750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Direttore | 19 Maggio 2023 A | 5.250 | 0 | 0 | $0 |
| Timothy R Pearson | Direttore | 19 Maggio 2023 A | 24.650 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Direttore | 19 Maggio 2023 A | 93.250 | 0 | 0 | $0 |
| James M Barrett | Direttore | 18 Maggio 2018 A | 4.995.664 | 0 | 0 | $0 |
| John J. Baldwin | Direttore | 29 Giugno 2016 M | 1.210 | 0 | 0 | $0 |
| Franklin H Top JR | Direttore | 17 Maggio 2016 A | 12.294 | 0 | 0 | $0 |
| Michael A Henos | Direttore | 15 Luglio 2015 A | 469.454 | 0 | 0 | $0 |
| William M. Gust | Direttore | 15 Gennaio 2014 C | 409.947 | 0 | 0 | $0 |
| Scott D. Sandell | Proprietario del 10% | 26 Gennaio 2023 S | 2.237.196 | 0 | 0 | $0 |
| Peter J Barris | Proprietario del 10% | 10 Maggio 2018 X | 4.995.664 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 depositi | 20 Luglio 2026 | 16,52% | Modifica | Investimento passivo | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 depositi | 20 Giugno 2025 | 0,37% | Modifica | — | SEC |
| 08 Maggio 2024 | — | Deposito iniziale | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 depositi | 29 Febbraio 2024 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 10 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,08% | 73.362 SH | 08 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,02% | 197.875 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 23.282 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 15.612 NS | 31 Maggio 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 529.441 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 124.281 SH | 08 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 83.801 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 661.946 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.832 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 39.408 SH | 08 Agosto 2026 | Giornaliero |